Chronic invasive aspergillosis caused by Aspergillus viridinutans.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

24 citing papers in PubMed, 56 citations in OpenAlex.

1. Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026
   Review
2. Functional neutrophil disorders: Chronic granulomatous disease and beyond.Immunological reviews · 2024
   Review
3. Accelerating the understanding ofCurrent research in microbial sciences · 2024
   Review
4. Of Mycelium and Men: Inherent Human Susceptibility to Fungal Diseases.Pathogens (Basel, Switzerland) · 2023
   Review
5. Efficacy of Olorofim (F901318) againstAntimicrobial agents and chemotherapy · 2019
   Article
6. Unravelling species boundaries in thePersoonia · 2018
   Article
7. EmergingOpen forum infectious diseases · 2018
   Review
8. Antifungal Susceptibility of the Aspergillus viridinutans Complex: Comparison of TwoAntimicrobial agents and chemotherapy · 2018
   Article
9. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.mBio · 2018
   Article
10. A Review of Chronic Granulomatous Disease.Advances in therapy · 2017
    Review
11. Triazole Resistance in Aspergillus spp.: A Worldwide Problem?Journal of fungi (Basel, Switzerland) · 2016
    Review
12. Aspergillus fumigatus-Related Species in Clinical Practice.Frontiers in microbiology · 2016
    Review
13. Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Review
14. Extrolites of Aspergillus fumigatus and Other Pathogenic Species in Aspergillus Section Fumigati.Frontiers in microbiology · 2015
    Review
15. Treatment of infections by cryptic Aspergillus species.Mycopathologia · 2014
    Review
16. Multi-resistant aspergillosis due to cryptic species.Mycopathologia · 2014
    Review
17. Antifungal susceptibility profile of cryptic species of Aspergillus.Mycopathologia · 2014
    Review
18. Aspergillus fumigatus and related species.Cold Spring Harbor perspectives in medicine · 2014
    Review
19. Genetic relatedness versus biological compatibility between Aspergillus fumigatus and related species.Journal of clinical microbiology · 2014
    Article
20. Chronic granulomatous disease.Hematology/oncology clinics of North America · 2013
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors at 3 institutions in 1 country.

Funding

Abstract

Indexed as